These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32043843)

  • 1. PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test.
    Vinciguerra G; Belcaro G; Feragalli B; Cesarone MR; Rotondi V; Ledda A; Zuccarini M; Hosoi M; Dugall M; Cacchio M; Cornelli U
    Panminerva Med; 2019 Dec; 61(4):457-463. PubMed ID: 32043843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress.
    Vinciguerra MG; Belcaro G; Cacchio M
    Minerva Cardioangiol; 2015 Oct; 63(5):403-9. PubMed ID: 26488613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G3 sports supplement in short triathlon: improvements in training, performance, recovery and oxidative stress.
    Belcaro G; Hu S; Strong J; Feragalli B; Vinciguerra G; Cacchio M; Cesarone MR
    Minerva Med; 2018 Dec; 109(6):451-456. PubMed ID: 30531697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy.
    Vinciguerra G; Belcaro G; Cesarone MR; Rohdewald P; Stuard S; Ricci A; Di Renzo A; Hosoi M; Dugall M; Ledda A; Cacchio M; Acerbi G; Fano F
    Angiology; 2006; 57(3):331-9. PubMed ID: 16703193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
    Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
    Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
    Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
    Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
    Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
    Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
    Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response.
    Belcaro G; Rohdewald P; Cesarone MR; Scipione C; Scipione V; Cornelli U; Luzzi R; Cotellese R; Dugall M; Hosoi M; Corsi M; Feragalli B
    Panminerva Med; 2022 Jun; 64(2):253-258. PubMed ID: 35815767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lady Prelox® improves sexual function in generally healthy women of reproductive age.
    Bottari A; Belcaro G; Ledda A; Luzzi R; Cesarone MR; Dugall M
    Minerva Ginecol; 2013 Aug; 65(4):435-44. PubMed ID: 24051943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in muscle strength and endurance of professional cyclists due to PycnoRacer
    Igawa T; Hara T; Ishizaka M; Sawaya Y; Ito A; Yakabi A; Kubo A
    J Phys Ther Sci; 2021 Apr; 33(4):339-344. PubMed ID: 33935358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary benign back pain: supplementation with Pycnogenol®.
    Cox D; Belcaro G; Cesarone MR; Cotellese R; Dugall M; Feragalli B; Hosoi M; Corsi M; Luzzi R
    Panminerva Med; 2021 Dec; 63(4):472-477. PubMed ID: 34915691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
    Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
    J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
    Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
    Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
    Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
    Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.